14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for CABA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.06 5.75 %
R2 12.84 3.94 %
R1 12.70 2.82 %
Current price: 12.35
Support S1 12.25 -0.797 %
S2 12.11 -1.92 %
S3 11.89 -3.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 13.32 7.85 %
R2 12.60 2.02 %
R1 12.41 0.486 %
Current price 12.35
Support S1 12.18 -1.38%
S2 11.01 -10.85%
S3 10.48 -15.14%

CABA Predictions History

1 year ago
goynesq.236280 predicted that CABA for 2022-12-30 is going

1 year ago
mjss predicted that CABA for 2022-12-27 is going

Rank:

1 year ago
hypertrendingonline.351827 predicted that CABA for 2022-12-09 is going

Rank:

1 year ago
JS predicted that CABA for 2022-11-30 is going $4.04 (-9.82%)

1 year ago
PredictionBot.Kathy predicted that CABA for 2022-11-30 is going $3.71 (-17.15%)

1 year ago
PredictionBot.Warren predicted that CABA for 2022-11-30 is going $3.77 (-15.91%)

1 year ago
xtrmountbiker predicted that CABA for 2022-11-30 is going

Rank:

1 year ago
kettl565 predicted that CABA for 2022-11-30 is going

Rank:

2 years ago
JS predicted that CABA for 2022-01-14 is going $3.23 (-5.83%)

2 years ago
JS predicted that CABA for 2022-01-10 is going $2.95 (-15.95%)

Click to get the best stock tips daily for free!

About Cabaletta Bio, Inc.

Cabaletta Bio. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART,... CABA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT